Mikro Mineraller ve Organizmadaki Görevleri

Verma S, Kumar S, Sharma S. Exploring the importance of trace elements in nutrition: understanding their vital role in health and well-being. E3S Web of Conferences. 2024;509:03016. doi:10.1051/e3sconf/202450903016.

Nielsen FH, Hunt JR. Trace elements emerging as important in human nutrition. In: Stumbo PJ, editor. Proceedings of the Fourteenth National Databank Conference. Iowa City: University of Iowa; 1989. p. 135-143.

Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews. 2013;2013(1). doi:10.1002/14651858.CD000980.pub4.

Underwood EJ, Mertz W. Trace elements in human and animal nutrition. Vol. 1. New York: Academic Press; 1986.

Skalny AV. Bioelements and bioelementology in pharmacology and nutrition: fundamental and practical aspects. In: Atroshi F, editor. Pharmacology and nutritional intervention in the treatment of disease. Rijeka: InTech; 2014. p. 225-241.

Horowitz GL, Altaie S, Boyd J, et al. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guidelines, 3rd ed. CLSI document C28-A3. Clinical and Laboratory Standards Institute (CLSI); 2008. 76 p.

Skalny AV, Kiselev MF, editors. Elemental status of the population of Russia. Part 2: Elemental status of the population of the Central Federal District. Saint Petersburg: Medkniga ELBI-SPb; 2011. 432 p.

Agadzhanian NA, Skalny AV. Chemical elements in the environment and the human ecological portrait. Moscow: KMK; 2001. 83 p.

Bogden JD, Klevay LM, editors. Clinical nutrition of the essential trace elements and minerals: The guide for health professionals. Totowa, NJ: Humana Press; 2010. 416 p.

Di Bona KR, Love S, Rhodes NR, et al. Chromium is not an essential trace element for mammals: effects of a “low-chromium” diet. J Biol Inorg Chem. 2011;16(3):381–90. doi:10.1007/s00775-010-0734-y.

WHO/FAO/IAEA. Trace elements in human nutrition and health. World Health Organization; 1996. p. 1–343. (21.10.2024 tarihinde https://apps.who.int/iris/handle/10665/37931 adresinden ulaşılmıştır).

Mertz W. Review of the scientific basis for establishing the essentiality of trace elements. Biol Trace Elem Res. 1998;66(1-3):185–91. doi:10.1007/BF02783137.

Anke M. Essential and toxic effects of macro, trace and ultratrace elements in the nutrition of man. In: Anke M, Merian E, Ihnat M, Stoeppler M, editors. Elements and their compounds in the environment. Vol. 1. Weinheim: Wiley-VCH; 2004. p. 343-367. doi:10.1002/9783527619634.ch16.

Oberleas D, Harland B, Skalny AV. Biological role of macro- and trace elements in humans and animals. Saint Petersburg: Nauka; 2008. 544 p.

Skalnaya MG, Skalny AV. Essential trace elements in human health: A physician’s view. Tomsk: Publishing House of Tomsk State University; 2018. 224 p.

Skalny AV, Skalnaya MG. Epidemiology of microelementoses in Russian children. In: Proceedings of the 19th Symp Mengen und Spurenelemente; 3-5 December 1999; Jena, Germany. Jena; 1999. p. 925-931.

Skalny AV, Skalnaya MG. The multielement hair analysis as a tool for preliminary evaluation of severe technogenic pollution effects on children’s health. In: Proceedings of the 4th Int Symp on Trace Elements in Humans: New Perspectives; 9-11 October 2003; Athens, Greece. Part I. Athens; 2003. p. 333-344.

Lindh U. Biological functions of the elements. In: Selinus O, editor. Essentials of medical geology. Dordrecht: Springer; 2013. p. 129-177. doi:10.1007/978-94-007-4375-5_7.

Otten JJ, Hellwig JP, Meyers LD, editors. Dietary reference intakes: The essential guide to nutrient requirements. Washington: National Academies Press; 2006. 1344 p.

Combs GF. Geological impacts on nutrition. In: Selinus O, editor. Essentials of medical geology. Dordrecht: Springer; 2013. p. 179-195. doi:10.1007/978-94-007-4375-5_8.

Skalny AV, Karganov MYu, Skalnaya MG, et al. Polysystemic investigation of children living in a megalopolis: environmental aspect. In: Karganov M, editor. Polysystemic approach to school, sport and environment medicine. Foster City: OMICS Group eBooks; 2014. p. 93-117.

Grabeklis AR, Skalny AV, Nechiporenko SP, et al. Indicator ability of biosubstances in monitoring the moderate occupational exposure to toxic metals. J Trace Elem Med Biol. 2011;25 Suppl 1: S41–S44. doi:10.1016/j.jtemb.2010.10.014.

Serebryansky EP, Skalny AV, Kuznetzov VV. Rapid ICP-OES determination of up to 20 essential and toxic elements in human hair for estimation of human microelemental status. In: Proceedings of the 21st Workshop on Macro and Trace Elements; 18-19 October 2002; Jena, Germany. Jena; 2002. p. 19-24.

Skalny AV, Kudrin AV. Radiation, trace elements, antioxidants and immunity (trace elements in restoration of health of Chernobyl veterans). Moscow: Lir Maket; 2000. 421 p.

Schwarz K, Mertz W. Chromium (III) and the glucose tolerance factor. Arch Biochem Biophys. 1959;85:292–5. doi:10.1016/0003-9861(59)90479-5.

Nordberg M, Cherian MG. Biological responses of elements. In: Selinus O, editor. Essentials of medical geology. Dordrecht: Springer; 2013. p. 195-214. doi:10.1007/978-94-007-4375-5_9.

Yoshida M. Is chromium an essential trace element in human nutrition? Nihon Eiseigaku Zasshi. 2012;67(4):485–91. doi:10.1265/jjh.67.485.

Skalny AV, Rudakov IA. Bioelements in medicine. Moscow; 2004. 271 p.

Lukaski HC. Chromium as a supplement. Annu Rev Nutr. 1999; 19:279–302. doi:10.1146/annurev.nutr.19.1.279.

Vincent JB. The biochemistry of chromium. J Nutr. 2000;130(4):715–8. doi:10.1093/jn/130.4.715.

Clodfelder BJ, Vincent JB. The time-dependent transport of chromium in adult rats from the bloodstream to the urine. J Biol Inorg Chem. 2005;10(4):383–93. doi:10.1007/s00775-005-0647-3.

Chen Y, Watson HM, Gao J, et al. Characterization of the organic component of low-molecular-weight chromium-binding substance and its binding of chromium. J Nutr. 2011;141(7):1225–32. doi:10.3945/jn.111.139147.

Wallach S, Verch RL. Placental transport of chromium. J Am Coll Nutr. 1984;3(1):69–74. doi:10.1080/07315724.1984.10720038.

Yamamoto A, Wada O, Manabe S. Evidence that chromium is an essential factor for biological activity of low-molecular-weight, chromium-binding substance. Biochem Biophys Res Commun. 1989;163(1):189–93. doi:10.1016/0006-291X(89)92119-0.

Wada O, Wu GY, Yamamoto A, et al. Purification and chromium-excretory function of low-molecular-weight, chromium-binding substances from dog liver. Environ Res. 1983;32(1):228–39. doi:10.1016/0013-9351(83)90210-4.

Vincent JB. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev. 2000;58(3 Pt 1):67–72. doi:10.1111/j.1753-4887.2000.tb01841.x.

Brock JH. Transferrins. In: Harrison PM, editor. Metalloproteins. Topics in Molecular and Structural Biology. London: Palgrave Macmillan; 1985. doi:10.1007/978-1-349-06375-8_5.

Quarles CD Jr, Brumaghim JL, Marcus RK. Instrumental comparison of the determination of Cr3+ uptake by human transferrin. Metallomics. 2010;2(12):792–9. doi:10.1039/c0mt00032a.

Quarles CD Jr, Marcus RK, Brumaghim JL. Competitive binding of Fe3+, Cr3+, and Ni2+ to transferrin. J Biol Inorg Chem. 2011;16(6):913–21. doi:10.1007/s00775-011-0792-9.

Clodfelder BJ, Emamaullee J, Hepburn DD, et al. The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. J Biol Inorg Chem. 2001;6(5-6):608–17. doi:10.1007/s007750100238.

Kandror KV. Insulin regulation of protein traffic in rat adipose cells. J Biol Chem. 1999;274(36):25210–7. doi:10.1074/jbc.274.36.25210.

Racek J. Chrom jako biogenní prvek. Chromium as an essential element. Cas Lek Cesk. 2003;142(6):335–9.

Davis CM, Sumrall KH, Vincent JB. A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry. 1996;35(39):12963–9. doi:10.1021/bi960328y.

Love ST, Di Bona KR, Sinha SH, et al. Urinary chromium excretion in response to an insulin challenge is not a biomarker for chromium status. Biol Trace Elem Res. 2013;152(1):57–65. doi:10.1007/s12011-012-9594-3.

Hua Y, Clark S, Ren J, et al. Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem. 2012;23(4):313–9. doi:10.1016/j.jnutbio.2011.11.001.

Sealls W, Penque BA, Elmendorf JS. Evidence that chromium modulates cellular cholesterol homeostasis and ABCA1 functionality impaired by hyperinsulinemia—brief report. Arterioscler Thromb Vasc Biol. 2011;31(5):1139–40. doi:10.1161/ATVBAHA.110.222158.

Goldstein BJ, Zhu L, Hager R, et al. Enhancement of post-receptor insulin signaling by trivalent chromium in hepatoma cells is associated with differential inhibition of specific protein-tyrosine phosphatases. J Trace Elem Exp Med. 2001;14(4):393–404. doi:10.1002/jtra.1050.

Dong F, Yang X, Sreejayan N, et al. Chromium (D-phenylalanine) 3 improves obesity-induced cardiac contractile defect in ob/ob mice. Obesity (Silver Spring, Md). 2007;15(11):2699–711. doi:10.1038/oby.2007.322.

Zhao P, Wang J, Ma H, et al. A newly synthetic chromium complex-chromium (D-phenylalanine) 3 activates AMP-activated protein kinase and stimulates glucose transport. Biochem Pharmacol. 2009;77(6):1002–10. doi:10.1016/j.bcp.2008.11.018.

Hao C, Hao J, Wang W, et al. Insulin sensitizing effects of oligomannuronate-chromium (III) complexes in C2C12 skeletal muscle cells. PLoS One. 2011;6(9). doi:10.1371/journal.pone.0024598.

Tuzcu M, Sahin N, Orhan C, et al. Impact of chromium histidinate on high fat diet induced obesity in rats. Nutr Metab (Lond). 2011;8:28. doi:10.1186/1743-7075-8-28.

Jain SK, Croad JL, Velusamy T, et al. Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Molecular Nutr Food Res. 2010;54(9):1371–80. doi:10.1002/mnfr.200900177.

Stupar J, Vrtovec M, Dolinsek F. Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus. Metabolism. 2007;56(1):94–104. doi:10.1016/j.metabol.2006.09.003.

Feng W, Ding W, Qian Q, et al. Use of the enriched stable isotope Cr-50 as a tracer to study the metabolism of chromium (III) in normal and diabetic rats. Biol Trace Elem Res. 1998;63(2):129–38. doi:10.1007/BF02778872.

Kazi TG, Afridi HI, Kazi N, et al. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res. 2008;122(1):1–18. doi:10.1007/s12011-007-8062-y.

Horton F, Wright J, Smith L, et al. Increased intestinal permeability to oral chromium (51 Cr)-EDTA in human Type 2 diabetes. Diabet Med. 2014;31(5):559–63. doi:10.1111/dme.12360.

Dogukan A, Sahin N, Tuzcu M, et al. The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biol Trace Elem Res. 2009;131(2):124–32. doi:10.1007/s12011-009-8351-8.

Tinkov AA, Popova EV, Polyakova VS, et al. Adipose tissue chromium and vanadium disbalance in high-fat fed Wistar rats. J Trace Elem Med Biol. 2015;29:176–81. doi:10.1016/j.jtemb.2014.07.006.

Morris BW, MacNeil S, Hardisty CA, et al. Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol. 1999;13(1-2):57–61. doi:10.1016/S0946-672X(99)80024-8.

Krikorian R, Eliassen JC, Boespflug EL, et al. Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr Neurosci. 2010;13(3):116–22. doi:10.1179/147683010X12611460764084.

Piotrowska A, Młyniec K, Siwek A, et al. Antidepressant-like effect of chromium chloride in the mouse forced swim test: involvement of glutamatergic and serotonergic receptors. Pharmacol Rep. 2008;60(6):991–5.

Davidson JR, Abraham K, Connor KM, et al. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry. 2003;53(3):261–4. doi:10.1016/s0006-3223(02)01500-7.

Ando Y. Analyses of pathogenesis and therapeutic approaches for hereditary amyloidosis. Rinsho Byori. 2003;51(6):530–5.

Olatunbosun DA, Bolodeoku JO, Cole TO, et al. Relationship of serum copper and zinc to human hypertension in Nigerians. Bull World Health Organ. 1976;53(1):134–5.

Skalny AV. Chemical elements in human physiology and ecology. Moscow: ONYX 21st Century Publishing House; 2004. 216 p.

Prohaska JR. Impact of copper deficiency in humans. Ann NY Acad Sci. 2014;1314:1–5. doi:10.1111/nyas.12354.

Prohaska JR. Role of copper transporters in copper homeostasis. Am J Clin Nutr. 2008;88(3):826S–9S. doi:10.1093/ajcn/88.3.826S.

Prohaska JR. Impact of copper limitation on expression and function of multicopper oxidases (ferroxidases). Adv Nutr (Bethesda, Md.). 2011;2(2):89–95. doi:10.3945/an.110.000208.

Gupta A, Lutsenko S. Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med Chem. 2009;1(6):1125–42. doi:10.4155/fmc.09.84.

Bertinato J, Cheung L, Hoque R, et al. Ctr1 transports silver into mammalian cells. J Trace Elem Med Biol. 2010;24(3):178–84. doi:10.1016/j.jtemb.2010.01.009.

Skalny AV, Grabeklis AR, Demidov VA, et al. Connection between morbidity and mineral status of population in the Central Federal District of Russia. Part 2. Essential and conditionally essential chemical elements. Trace Elem Med (Moscow). 2012;13(2):1–7.

Saha A, Karnik A, Sathawara N, et al. Ceruloplasmin as a marker of occupational copper exposure. J Expo Sci Environ Epidemiol. 2008;18(3):332–7. doi:10.1038/jes.2008.2.

Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med. 2003;7(2):113–26. doi:10.1111/j.1582-4934.2003.tb00210.x.

Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85(5):1185–96. doi:10.1093/ajcn/85.5.1185.

Lugović-Mihić L, Seserko A, Duvancić T, et al. Histamine intolerance--possible dermatologic sequences. Acta Med Croatica. 2012;66(5):375–81.

Agúndez JA, Ayuso P, Cornejo-García JA, et al. The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs. PLoS One. 2012;7(11). doi:10.1371/journal.pone.0047571.

Sturza A, Mirică SN, Duicu O, et al. Monoamine oxidase--a inhibition reverses endothelial dysfunction in hypertensive rat aortic rings. Rev Med Chir Soc Med Nat Iasi. 2013;117(1):165–71. doi:10.1139/cjpp-2014-054.

Kaludercic N, Carpi A, Nagayama T, et al. Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. Antioxid Redox Signal. 2014;20(2):267–80. doi:10.1089/ars.2012.4616.

Wang F, Huang B, Li J, et al. Renalase might be associated with hypertension and insulin resistance in Type 2 diabetes. Ren Fail. 2014;36(4):552–6. doi:10.3109/0886022X.2013.876352.

Sturza A, Leisegang MS, Babelova A, et al. Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension (Dallas). 2013;62(1):140–6. doi:10.1161/HYPERTENSIONAHA.113.01314.

Sorato E, Menazza S, Zulian A, et al. Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies. Free Radic Biol Med. 2014;75:40–7. doi:10.1016/j.freeradbiomed.2014.07.006.

Chauhan A, Chauhan V, Brown WT, et al. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci. 2004;75(21):2539–49. doi:10.1016/j.lfs.2004.04.038.

Russo AJ, Bazin AP, Bigega R, et al. Plasma copper and zinc concentration in individuals with autism correlate with selected symptom severity. Nutr Metab Insights. 2012;5:41–7. doi:10.4137/NMI.S8761.

Kim SK, Park HJ, Seok H, et al. Association study between monoamine oxidase A (MAOA) gene polymorphisms and schizophrenia: lack of association with schizophrenia and possible association with affective disturbances of schizophrenia. Mol Biol Rep. 2014;41(5):3457–64. doi:10.1007/s11033-014-3207-5.

Olatunbosun DA, Akindele MO, Adadevoh BK, et al. Serum copper in schizophrenia in Nigerians. Br J Psychiatry. 1975;127:119–21. doi:10.1192/bjp.127.2.119.

Kadrabová J, Madáric A, Sustrová M, et al. Changed serum trace element profile in Down’s syndrome. Biol Trace Elem Res. 1996;54(3):201–6. doi:10.1007/BF02784431.

Ozturk P, Kurutas E, Ataseven A, et al. BMI and levels of zinc, copper in hair, serum and urine of Turkish male patients with androgenetic alopecia. J Trace Elem Med Biol. 2014;28(3):266–70. doi:10.1016/j.jtemb.2014.03.003.

Semenov AS, Skalny AV. Immunopathological and pathobiochemical aspects of pathogenesis of prenatal cerebral lesions (cerebral palsy, fetal alcohol syndrome). Lviv: Papuga; 2013. p. 352.

Bligt-Lindén E, Pihlavisto M, Szatmári I, et al. Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode. J Med Chem. 2013;56(24):9837–48. doi:10.1021/jm401372d.

Murata M, Noda K, Fukuhara J, et al. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012;53(7):4055–62. doi:10.1167/iovs.12-9857.

Zlatkov NB, Bozhkov B, Genov D. Serum copper and ceruloplasmin in patients with psoriasis after helio- and thalassotherapy. Arch Dermatol Res. 1973;247(3):289–94. doi:10.1007/BF00596249.

Senard JM, Rouet P. Dopamine beta-hydroxylase deficiency. Orphanet J Rare Dis. 2006;1:7. doi:10.1186/1750-1172-1-7.

Komori Y, Imai M, Yamauchi T, et al. Effect of p-aminophenols on tyrosinase activity. Bioorg Med Chem. 2014;22(15):3994–4000. doi:10.1016/j.bmc.2014.05.073.

Boisseau-Garsaud AM, Garsaud P, Lejoly-Boisseau H, et al. Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo. Int J Dermatol. 2002;41(10):640–2. doi:10.1046/j.1365-4362.2002.01472.x.

Jain D, Misra R, Kumar A, et al. Levels of malondialdehyde and antioxidants in the blood of patients with vitiligo of age group 11-20 years. Indian J Physiol Pharmacol. 2008;52(3):297–301.

Xiao Q, Ge G. Lysyl oxidase, extracellular matrix remodeling and cancer metastasis. Cancer Microenviron. 2012;5(3):261–73. doi:10.1007/s12307-012-0105-z.

Siddikuzzaman, Grace VM, Guruvayoorappan C. Lysyl oxidase: a potential target for cancer therapy. Inflammopharmacology. 2011;19(3):117–29. doi:10.1007/s10787-010-0073-1.

López B, González A, Hermida N, et al. Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects. Am J Physiol Heart Circ Physiol. 2010;299(1) –H9. doi:10.1152/ajpheart.00335.2010.

Debray FG, Seneca S, Gonce M, et al. Mitochondrial encephalomyopathy with cytochrome c oxidase deficiency caused by a novel mutation in the MTCO1 gene. Mitochondrion. 2014;17:101–5. doi:10.1016/j.mito.2014.06.003.

Jin T, Shen H, Zhao Z, et al. Clinical, pathological, and neuroimaging analyses of two cases of Leigh syndrome in a Chinese family. J Child Neurol. 2014;29(11)–NP148. doi:10.1177/0883073813512524.

Schmidlin T, Kennedy BK, Daggett V. Structural changes to monomeric CuZn superoxide dismutase caused by the familial amyotrophic lateral sclerosis-associated mutation A4V. Biophys J. 2009;97(6):1709–18. doi:10.1016/j.bpj.2009.06.043.

Bousquet-Moore D, Ma XM, Nillni EA, et al. Reversal of physiological deficits caused by diminished levels of peptidylglycine alpha-amidating monooxygenase by dietary copper. Endocrinology. 2009;150(4):1739–47. doi:10.1210/en.2008-1202.

Dumitriu L, Bartoc R, Ursu H, et al. Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism. Endocrinologie. 1988;26(1):35–8.

Arcucci A, Ruocco MR, Amatruda N, et al. Analysis of extracellular superoxide dismutase in fibroblasts from patients with systemic sclerosis. J Biol Regul Homeost Agents. 2011;25(4):647–54.

Kuźma-Kozakiewicz M, Berdyński M, Morita M, et al. Recurrent K3E mutation in Cu/Zn superoxide dismutase gene associated with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7-8):608–14. doi:10.3109/21678421.2013.812119.

Leming C. Comparative study on ferrum and copper level of hair and ending capillary of children with anemia. Trace Elem Sci. 1998;12:001.

Sampath P, Mazumder B, Seshadri V, et al. Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3’ untranslated region. Mol Cell Biol. 2003;23(5):1509–19. doi:10.1128/MCB.23.5.1509-1519.2003.

Haga P. Ceruloplasmin levels and erythrocyte superoxide dismutase activity in small preterm infants during the early anemia of prematurity. Acta Paediatr Scand. 1981;70(6):861–4. doi:10.1111/j.1651-2227.1981.tb06240.x.

Aigner E, Hinz C, Steiner K, et al. Iron stores, liver transaminase levels and metabolic risk in healthy teenagers. Eur J Clin Invest. 2010;40(2):155–63. doi:10.1111/j.1365-2362.2009.02238.x.

Vashchenko G, MacGillivray RT. Multi-copper oxidases and human iron metabolism. Nutrients. 2013;5(7):2289–2313. doi:10.3390/nu5072289.

Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–54. doi:10.1056/NEJM199902113400607.

Texel SJ, Xu X, Harris ZL. Ceruloplasmin in neurodegenerative diseases. Biochem Soc Trans. 2008;36(Pt 6):1277–81. doi:10.1042/BST0361277.

Rossi-George A, Guo CJ, Oakes BL, et al. Copper modulates the phenotypic response of activated BV2 microglia through the release of nitric oxide. Nitric Oxide. 2012;27(4):201–9. doi:10.1016/j.niox.2012.07.002.

Squitti R, Quattrocchi CC, Salustri C, et al. Ceruloplasmin fragmentation is implicated in ‘free’ copper deregulation of Alzheimer’s disease. Prion. 2008;2(1):23–7. doi:10.4161/pri.2.1.6297.

Squitti R. Copper dysfunction in Alzheimer’s disease: from meta-analysis of biochemical studies to new insight into genetics. J Trace Elem Med Biol. 2012;26(2-3):93–6. doi:10.1016/j.jtemb.2012.04.012.

Spisni E, Valerii MC, Manerba M, et al. Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons. Neurotoxicology. 2009;30(4):605–12. doi:10.1016/j.neuro.2009.03.005.

Jomova K, Vondrakova D, Lawson M, et al. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem. 2010;345(1-2):91–104. doi:10.1007/s11010-010-0563-x.

Singh I, Sagare AP, Coma M, et al. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A. 2013;110(36):14771–6. doi:10.1073/pnas.1302212110.

Bharucha KJ, Friedman JK, Vincent AS, et al. Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson’s disease. J Neurol. 2008;255(12):1957–62. doi:10.1007/s00415-009-0063-7.

Senra Varela A, Lopez Saez JJ, Quintela Senra D. Serum ceruloplasmin as a diagnostic marker of cancer. Cancer Lett. 1997;121(2):139–45. doi:10.1016/s0304-3835(97)00340-6.

Biesalski HK, Kohrle J, Schumann K. Vitamine, Spurenelemente und Mineralstoffe. Stuttgart: Thieme; 2002. 774 p.

Avtsyn AP, Zhavoronkov AA, Rish MA, et al. Human microelementoses: etiology, classification, organopathology. Moscow: Meditsina; 1991. 496 p.

Xu J, Zhou Q, Liu G, et al. Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications. Oxid Med Cell Longev. 2013;2013:635214. doi:10.1155/2013/635214.

Memişoğullari R, Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. J Diabetes Complications. 2004;18(4):193–7. doi:10.1016/S1056-8727(03)00032-1.

Eck PC, Wilson L. Copper Toxicity. Eck Institute of Applied Nutrition and Bioenergetics Ltd; Feniks, AZ, USA: 1989. p. 1–16. (03.11.2024 tarihinde http://austin3dhealth.com/documents/Copper%20Handout%20from%20ARL.pdf. adresinden ulaşılmıştır).

Verma GR, Pandey AK, Bose SM, et al. Study of serum calcium and trace elements in chronic cholelithiasis. ANZ J Surg. 2002;72(8):596–9. doi:10.1046/j.1445-2197.2002.02485.x.

Krishnamurthy GT, Krishnamurthy S. Extrahepatic cholestasis. In: Krishnamurthy GT, Krishnamurthy S, editors. Nuclear Hepatology. Berlin Heidelberg: Springer; 2009. p. 211–41.

Burrows S, Pekala B. Serum copper and ceruloplasmin in pregnancy. Am J Obstet Gynecol. 1971;109(6):907–9. doi:10.1016/0002-9378(71)90805-2.

Tisato F, Marzano C, Porchia M, et al. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev. 2010;30(4):708–49. doi:10.1002/med.20174.

Chen H, Attieh ZK, Su T, et al. Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia mice. Blood. 2004;103(10):3933–9. doi:10.1182/blood-2003-09-3139.

Prohaska JR, Broderius M. Copper deficiency has minimal impact on ferroportin expression or function. Biometals. 2012;25(4):633–42. doi:10.1007/s10534-012-9521-2.

Chen H, Attieh ZK, Syed BA, et al. Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells. J Nutr. 2010;140(10):1728–35. doi:10.3945/jn.109.117531.

Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med (Cambridge, Mass.). 2008;14(5-6):353–7. doi:10.2119/2008-00033.Prasad.

Rink L, Haase H. Zinc homeostasis and immunity. Trends Immunol. 2007;28(1):1–4. doi:10.1016/j.it.2006.11.005.

MacDiarmid CW, Gaither LA, Eide D. Zinc transporters that regulate vacuolar zinc storage in Saccharomyces cerevisiae. EMBO J. 2000;19(12):2845–55. doi:10.1093/emboj/19.12.2845.

Rutter GA. Think zinc: New roles for zinc in the control of insulin secretion. Islets. 2010;2(1):49–50. doi:10.4161/isl.2.1.10259.

John E, Laskow TC, Buchser WJ, et al. Zinc in innate and adaptive tumor immunity. J Transl Med. 2010;8:118. doi:10.1186/1479-5876-8-118.

Mocchegiani E, Romeo J, Malavolta M, et al. Zinc: dietary intake and impact of supplementation on immune function in elderly. Age (Dordrecht, Netherlands). 2013;35(3):839–60. doi:10.1007/s11357-011-9377-3.

Bosco MD, Mohanasundaram DM, Drogemuller CJ, et al. Zinc and zinc transporter regulation in pancreatic islets and the potential role of zinc in islet transplantation. Rev Diabetic Stud. 2010;7(4):263–74. doi:10.1900/RDS.2010.7.263.

Jeong J, Eide DJ. The SLC39 family of zinc transporters. Mol Aspects Med. 2013;34(2-3):612–9. doi:10.1016/j.mam.2012.05.011.

Wages PA, Silbajoris R, Speen A, et al. Role of H2O2 in the oxidative effects of zinc exposure in human airway epithelial cells. Redox Biol. 2014;3:47–55. doi:10.1016/j.redox.2014.10.005.

Fukada T, Yamasaki S, Nishida K, et al. Zinc homeostasis and signaling in health and diseases: Zinc signaling. J Biol Inorg Chem. 2011;16(7):1123–34. doi:10.1007/s00775-011-0797-4.

Brooks SP, Oberleas D, Dawson BA, et al. Proposed phytic acid standard including a method for its analysis. J AOAC Int. 2001;84(4):1125–9.

Hunt JR, Beiseigel JM. Dietary calcium does not exacerbate phytate inhibition of zinc absorption by women from conventional diets. Am J Clin Nutr. 2009;89(3):839–43. doi:10.3945/ajcn.2008.27175.

Oestreicher P, Cousins RJ. Copper and zinc absorption in the rat: mechanism of mutual antagonism. J Nutr. 1985;115(2):159–66. doi:10.1093/jn/115.2.159.

Volosovets OP, Kryvopustov SP, Cherniy EF, et al. About the role of zinc in clinical pediatrics. Children’s Doctor. 2012;5(18):37–9.

Brzóska MM, Moniuszko-Jakoniuk J. Interactions between cadmium and zinc in the organism. Food Chem Toxicol. 2001;39(10):967–80. doi:10.1016/s0278-6915(01)00048-5.

Freisinger E, Vašák M. Cadmium in metallothioneins. In: Sigel A, Sigel H, Sigel RKO, editors. Metal Ions in Life Sciences. Vol. 11. Dordrecht: Springer; 2013. p. 339–71. doi:10.1007/978-94-007-5179-8_11.

Fujishiro H, Yano Y, Takada Y, et al. Roles of ZIP8, ZIP14, and DMT1 in transport of cadmium and manganese in mouse kidney proximal tubule cells. Metallomics. 2012;4(7):700–8. doi:10.1039/c2mt20024d.

Rentschler G, Kippler M, Axmon A, et al. Cadmium concentrations in human blood and urine are associated with polymorphisms in zinc transporter genes. Metallomics. 2014;6(4):885–91. doi:10.1039/c3mt00365e.

Mori S, Pawankar R, Ozu C, et al. Expression and roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in allergic nasal mucosa. Allergy Asthma Immunol Res. 2012;4(4):231–9. doi:10.4168/aair.2012.4.4.231.

Niu W, Qi Y. Matrix metalloproteinase family gene polymorphisms and risk for coronary artery disease: systematic review and meta-analysis. Heart (Br Card Soc). 2012;98(20):1483–91. doi:10.1136/heartjnl-2012-302085.

Prasad AS. Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr (Bethesda, Md). 2013;4(2):176–90. doi:10.3945/an.112.003210.

Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids. 2011;41(2):271–90. doi:10.1007/s00726-010-0689-x.

Moroz OV, Burkitt W, Wittkowski H, et al. Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. BMC Biochem. 2009;10:11. doi:10.1186/1471-2091-10-11.

Aliev G, Li Y, Chubarev VN, et al. Application of Acyzol in the context of zinc deficiency and perspectives. Int J Mol Sci. 2019;20(9):2104. doi:10.3390/ijms20092104.

Mocchegiani E, Muzzioli M, Giacconi R, et al. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev. 2003;124(4):459–68. doi:10.1016/s0047-6374(03)00023-x.

Gyulkhandanyan AV, Lu H, Lee SC, et al. Investigation of transport mechanisms and regulation of intracellular Zn2+ in pancreatic alpha-cells. J Biol Chem. 2008;283(15):10184–97. doi:10.1074/jbc.M707005200.

Kawasaki E. ZnT8 and type 1 diabetes. Endocr J. 2012;59(7):531–7. doi:10.1507/endocrj.ej12-0069.

Kurji K, Sharma RK. Potential role of calcineurin in pathogenic conditions. Mol Cell Biochem. 2010;338(1-2):133–41. doi:10.1007/s11010-009-0346-4.

Zuo Y, Selvakumar P, Sharma RK. Molecular cloning and biochemical characterization of bovine retina calcineurin. Mol Cell Biochem. 2010;333(1-2):73–82. doi:10.1007/s11010-009-0206-2.

Agbas A, Hui D, Wang X, et al. Activation of brain calcineurin (Cn) by Cu-Zn superoxide dismutase (SOD1) depends on direct SOD1-Cn protein interactions occurring in vitro and in vivo. Biochem J. 2007;405(1):51–9. doi:10.1042/BJ20061202.

Vaos G, Kostakis ID, Zavras N, et al. The role of calprotectin in pediatric disease. Biomed Res Int. 2013;2013:542363. doi:10.1155/2013/542363.

Hatfield DL, Tsuji PA, Carlson BA, et al. Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci. 2014;39(3):112–20. doi:10.1016/j.tibs.2013.12.007.

Zhang Y, Gladyshev VN. Comparative genomics of trace element dependence in biology. J Biol Chem. 2011;286(27):23623–9. doi:10.1074/jbc.R110.172833.

Gladyshev VN, Martin-Romero FJ, Xu XM, Kumaraswamy E, Carlson BA, Hatfield DL, Lee BJ. Molecular biology of selenium and its role in cancer, AIDS and other human diseases. Recent Res Dev Biochem. 1999;1:145–67.

Hill KE, Wu S, Motley AK, et al. Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis. J Biol Chem. 2012;287(48):40414–24. doi:10.1074/jbc.M112.421404.

Misra S, Kwong RW, Niyogi S. Transport of selenium across the plasma membrane of primary hepatocytes and enterocytes of rainbow trout. J Exp Biol. 2012;215(Pt 9):1491–501. doi:10.1242/jeb.062307.

Combs GF, Jr. Biomarkers of selenium status. Nutrients. 2015;7(4):2209–36. doi:10.3390/nu7042209.

Steinbrenner H, Hotze AL, Speckmann B, et al. Localization and regulation of pancreatic selenoprotein P. J Mol Endocrinol. 2012;50(1):31–42. doi:10.1530/JME-12-0105.

Mao J, Teng W. The relationship between selenoprotein P and glucose metabolism in experimental studies. Nutrients. 2013;5(6):1937–48. doi:10.3390/nu5061937.

Rosen BP, Liu Z. Transport pathways for arsenic and selenium: a minireview. Environ Int. 2009;35(3):512–5. doi:10.1016/j.envint.2008.07.023.

Usuki F, Yamashita A, Fujimura M. Post-transcriptional defects of antioxidant selenoenzymes cause oxidative stress under methylmercury exposure. J Biol Chem. 2011;286(8):6641–9. doi:10.1074/jbc.M110.168872.

Kurokawa S, Bellinger FP, Hill KE, et al. Isoform-specific binding of selenoprotein P to the β-propeller domain of apolipoprotein E receptor 2 mediates selenium supply. J Biol Chem. 2014;289(13):9195–207. doi:10.1074/jbc.M114.549014.

Yang W, Diamond AM. Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome. Biomarker Res. 2013;1(1):15. doi:10.1186/2050-7771-1-15.

Carlson BA, Yoo MH, Tobe R, et al. Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis. 2012;33(9):1806–13. doi:10.1093/carcin/bgs230.

Duntas LH. The role of selenium in thyroid autoimmunity and cancer. Thyroid. 2006;16(5):455–60. doi:10.1089/thy.2006.16.455.

Verma S, Hoffmann FW, Kumar M, et al. Selenoprotein K knockout mice exhibit deficient calcium flux in immune cells and impaired immune responses. J Immunol. 2011;186(4):2127–37. doi:10.4049/jimmunol.1002878.

Schoenmakers E, Agostini M, Mitchell C, et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest. 2010;120(12):4220–35. doi:10.1172/JCI43653.

Zhou X, Smith AM, Failla ML, et al. Estrogen status alters tissue distribution and metabolism of selenium in female rats. J Nutr Biochem. 2012;23(6):532–8. doi:10.1016/j.jnutbio.2011.02.008.

Rock C, Moos PJ. Selenoprotein P regulation by the glucocorticoid receptor. Biometals. 2009;22(6):995–1009. doi:10.1007/s10534-009-9251-2.

Bellinger FP, Raman AV, Reeves MA, et al. Regulation and function of selenoproteins in human disease. Biochem J. 2009;422(1):11–22. doi:10.1042/BJ20090219.

Huang Z, Rose AH, Hoffmann PR. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2012;16(7):705–43. doi:10.1089/ars.2011.4145.

Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res. 1997;56(1):117–24. doi:10.1007/BF02778987.

Ghashut RA, McMillan DC, Kinsella J, et al. The effect of the systemic inflammatory response on plasma zinc and selenium adjusted for albumin. Clin Nutr. 2016;35(2):381–7. doi:10.1016/j.clnu.2015.02.010.

Wallenberg M, Olm E, Hebert C, et al. Selenium compounds are substrates for glutaredoxins: a novel pathway for selenium metabolism and a potential mechanism for selenium-mediated cytotoxicity. Biochem J. 2010;429(1):85–93. doi:10.1042/BJ20100368.

Rocourt CR, Cheng WH. Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance? Nutrients. 2013;5(4):1349–65. doi:10.3390/nu5041349.

Wang Y, Fang W, Huang Y, et al. Reduction of selenium-binding protein 1 sensitizes cancer cells to selenite via elevating extracellular glutathione: a novel mechanism of cancer-specific cytotoxicity of selenite. Free Radic Biol Med. 2015;79:186–96. doi:10.1016/j.freeradbiomed.2014.11.015.

Michaelis M, Gralla O, Behrends T, et al. Selenoprotein P in seminal fluid is a novel biomarker of sperm quality. Biochem Biophys Res Commun. 2014;443(3):905–10. doi:10.1016/j.bbrc.2013.12.067.

Cheng AW, Stabler TV, Bolognesi M, et al. Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthritis Cartilage. 2011;19(1):118–25. doi:10.1016/j.joca.2010.10.019.

Zhang Z, Zhang J, Xiao J. Selenoproteins and selenium status in bone physiology and pathology. Biochim Biophys Acta. 2014;1840(11):3246–56. doi:10.1016/j.bbagen.2014.08.001.

Schomburg L. Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat Rev Endocrinol. 2011;8(3):160–71. doi:10.1038/nrendo.2011.174.

Drutel A, Archambeaud F, Caron P. Selenium and the thyroid gland: more good news for clinicians. Clin Endocrinol (Oxf). 2013;78(2):155–64. doi:10.1111/cen.12066.

Dumitrescu AM, Refetoff S. Inherited defects of thyroid hormone metabolism. Ann Endocrinol (Paris). 2011;72(2):95–8. doi:10.1016/j.ando.2011.03.011.

Mittag J, Behrends T, Hoefig CS, et al. Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLoS One. 2010;5(9). doi:10.1371/journal.pone.0012931.

St Germain DL, Galton VA, Hernandez A. Minireview: defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology. 2009;150(3):1097–107. doi:10.1210/en.2008-1588.

Tanguy Y, Falluel-Morel A, Arthaud S, et al. The PACAP-regulated gene selenoprotein T is highly induced in nervous, endocrine, and metabolic tissues during ontogenetic and regenerative processes. Endocrinology. 2011;152(11):4322–35. doi:10.1210/en.2011-1246.

Prevost G, Arabo A, Jian L, et al. The PACAP-regulated gene selenoprotein T is abundantly expressed in mouse and human β-cells and its targeted inactivation impairs glucose tolerance. Endocrinology. 2013;154(10):3796–806. doi:10.1210/en.2013-1167.

Grumolato L, Ghzili H, Montero-Hadjadje M, et al. Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J. 2008;22(6):1756–68. doi:10.1096/fj.06-075820.

Balthasar N. Genetic dissection of neuronal pathways controlling energy homeostasis. Obesity (Silver Spring). 2006;14 Suppl 5:222S–7S. doi:10.1038/oby.2006.313.

Purkayastha S, Zhang H, Zhang G, et al. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc Natl Acad Sci U S A. 2011;108(7):2939–44. doi:10.1073/pnas.1006875108.

Pitts MW, Reeves MA, Hashimoto AC, et al. Deletion of selenoprotein M leads to obesity without cognitive deficits. J Biol Chem. 2013;288(36):26121–34. doi:10.1074/jbc.M113.471235.

Speckmann B, Steinbrenner H. Selenium and selenoproteins in inflammatory bowel diseases and experimental colitis. Inflamm Bowel Dis. 2014;20(6):1110–9. doi:10.1097/MIB.0000000000000020.

Kaushal N, Kudva AK, Patterson AD, et al. Crucial role of macrophage selenoproteins in experimental colitis. J Immunol. 2014;193(7):3683–92. doi:10.4049/jimmunol.1400347.

Schomburg L, Schweizer U, Holtmann B, et al. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J. 2003;370(Pt 2):397–402. doi:10.1042/BJ20021853.

Zhang Y, Zhou Y, Schweizer U, et al. Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals. J Biol Chem. 2008;283(4):2427–38. doi:10.1074/jbc.M707951200.

Raymond LJ, Deth RC, Ralston NV. Potential role of selenoenzymes and antioxidant metabolism in relation to autism etiology and pathology. Autism Res Treat. 2014;2014:164938. doi:10.1155/2014/164938.

Salonen JT, Alfthan G, Huttunen JK, et al. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982;2(8291):175–9. doi:10.1016/s0140-6736(82)91028-5.

Peng T, Li Y, Yang Y, et al. Characterization of enterovirus isolates from patients with heart muscle disease in a selenium-deficient area of China. J Clin Microbiol. 2000;38(10):3538–43. doi:10.1128/JCM.38.10.3538-3543.2000.

Rivera MT, de Souza AP, Hasslocher-Moreno AM, et al. Progressive Chagas’ cardiomyopathy is associated with low selenium levels. Am J Trop Med Hyg. 2002;66(6):706–12. doi:10.4269/ajtmh.2002.66.706.

Steinbrenner H, Alili L, Bilgic E, et al. Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radic Biol Med. 2006;40(9):1513–23. doi:10.1016/j.freeradbiomed.2005.12.022.

Maulik N, Yoshida T, Das DK. Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase. Mol Cell Biochem. 1999;196(1-2):13–21. doi:10.1007/978-1-4615-5097-6_2.

Voetsch B, Jin RC, Bierl C, et al. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke. 2007;38(1):41–9. doi:10.1161/01.STR.0000252027.53766.2b.

Seiler A, Schneider M, Förster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8(3):237–48. doi:10.1016/j.cmet.2008.07.005.

Seale LA, Hashimoto AC, Kurokawa S, et al. Disruption of the selenocysteine lyase-mediated selenium recycling pathway leads to metabolic syndrome in mice. Mol Cell Biol. 2012;32(20):4141–54. doi:10.1128/MCB.00293-12.

Turnlund JR, Weaver CM, Kim SK, et al. Molybdenum absorption and utilization in humans from soy and kale intrinsically labeled with stable isotopes of molybdenum. Am J Clin Nutr. 1999;69(6):1217–23. doi:10.1093/ajcn/69.6.1217.

Mendel RR, Kruse T. Cell biology of molybdenum in plants and humans. Biochim Biophys Acta. 2012;1823(9):1568–79. doi:10.1016/j.bbamcr.2012.02.007.

Turnlund JR, Keyes WR, Peiffer GL. Molybdenum absorption, excretion, and retention studied with stable isotopes in young men at five intakes of dietary molybdenum. Am J Clin Nutr. 1995;62(4):790–6. doi:10.1093/ajcn/62.4.790.

NRC National Research Council (US) Subcommittee on the Tenth Edition of the Recommended Dietary Allowances. Recommended Dietary Allowances: 10th Edition. National Academies Press (US); 1989. 284 p. doi:10.17226/1349.

Novotny JA, Turnlund JR. Molybdenum kinetics in men differ during molybdenum depletion and repletion. J Nutr. 2006;136(4):953–7. doi:10.1093/jn/136.4.953.

Novotny JA, Turnlund JR. Molybdenum intake influences molybdenum kinetics in men. J Nutr. 2007;137(1):37–42. doi:10.1093/jn/137.1.37.

Tejada-Jiménez M, Galván A, Fernández E. Algae and humans share a molybdate transporter. Proc Natl Acad Sci U S A. 2011;108(16):6420–5. doi:10.1073/pnas.1100700108.

Reiss J, Johnson JL. Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH. Hum Mutat. 2003;21(6):569–76. doi:10.1002/humu.10223.

Hanzelmann P, Hernandez HL, Menzel C, et al. Characterization of MOCS1A, an oxygen-sensitive iron-sulfur protein involved in human molybdenum cofactor biosynthesis. J Biol Chem. 2004;279(33):34721–32. doi:10.1074/jbc.M313398200.

Hanzelmann P, Schwarz G, Mendel RR. Functionality of alternative splice forms of the first enzymes involved in human molybdenum cofactor biosynthesis. J Biol Chem. 2002;277(21):18303–12. doi:10.1074/jbc.M200947200.

Santamaria-Araujo JA, Fischer B, Otte T, et al. The tetrahydropyranopterin structure of the sulfur-free and metal-free molybdenum cofactor precursor. J Biol Chem. 2004;279(16):15994–9. doi:10.1074/jbc.M311815200.

Matthies A, Rajagopalan KV, Mendel RR, et al. Evidence for the physiological role of a rhodanese-like protein for the biosynthesis of the molybdenum cofactor in humans. Proc Natl Acad Sci U S A. 2004;101(16):5946–51. doi:10.1073/pnas.0308191101.

Marelja Z, Stöcklein W, Nimtz M, et al. A novel role for human Nfs1 in the cytoplasm: Nfs1 acts as a sulfur donor for MOCS3, a protein involved in molybdenum cofactor biosynthesis. J Biol Chem. 2008;283(37):25178–85. doi:10.1074/jbc.M804064200.

Llamas A, Mendel RR, Schwarz G. Synthesis of adenylated molybdopterin: an essential step for molybdenum insertion. J Biol Chem. 2004;279(53):55241–6. doi:10.1074/jbc.M409862200.

Feng G, Tintrup H, Kirsch J, et al. Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. Science. 1998;282(5392):1321–4. doi:10.1126/science.282.5392.1321.

Rajagopalan KV, Johnson JL. The pterin molybdenum cofactors. J Biol Chem. 1992;267(15):10199–202.

Zhang Y, Gladyshev VN. Comparative genomics of trace elements: emerging dynamic view of trace element utilization and function. Chem Rev. 2009;109(10):4828–61. doi:10.1021/cr800557s.

Anke MK. Molybdenum. In: Merian E, Anke M, Ihnat M, Stoeppler M, editors. Elements and their compounds in the environment. Weinheim: Wiley-VCH Verlag; 2004. p. 1007–37. doi:10.1002/9783527619634.ch39.

Ichida K, Amaya Y, Okamoto K, et al. Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans. Int J Mol Sci. 2012;13(11):15475–95. doi:10.3390/ijms131115475.

Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87–114. doi:10.1124/pr.58.1.6.

Guerciolini R, Szumlanski C, Weinshilboum RM. Human liver xanthine oxidase: nature and extent of individual variation. Clin Pharmacol Ther. 1991;50(6):663–72. doi:10.1038/clpt.1991.205.

Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7(2):156–67. doi:10.1038/nrd2466.

Nishino T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem. 1994;116(1):1–6. doi:10.1093/oxfordjournals.jbchem.a124480.

Rodríguez-Trelles F, Tarrío R, Ayala FJ. Convergent neofunctionalization by positive Darwinian selection after ancient recurrent duplications of the xanthine dehydrogenase gene. Proc Natl Acad Sci U S A. 2003;100(23):13413–7. doi:10.1073/pnas.183564610.

Garattini E, Fratelli M, Terao M. Mammalian aldehyde oxidases: genetics, evolution and biochemistry. Cell Mol Life Sci. 2008;65(7-8):1019–48. doi:10.1007/s00018-007-7398-y.

Shaw S, Jayatilleke E. The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat. Biochem J. 1990;268(3):579–83. doi:10.1042/bj2680579.

Havemeyer A, Lang J, Clement B. The fourth mammalian molybdenum enzyme mARC: current state of research. Drug Metab Rev. 2011;43(4):524–39. doi:10.3109/03602532.2011.608682.

Seelig MS. Review: relationships of copper and molybdenum to iron metabolism. Am J Clin Nutr. 1972;25(10):1022–37. doi:10.1093/ajcn/25.10.1022.

Flores CR, Puga MP, Wrobel K, et al. Trace elements status in diabetes mellitus type 2: possible role of the interaction between molybdenum and copper in the progress of typical complications. Diabetes Res Clin Pract. 2011;91(3):333–41. doi:10.1016/j.diabres.2010.12.014.

Lewis RC, Meeker JD. Biomarkers of exposure to molybdenum and other metals in relation to testosterone among men from the United States National Health and Nutrition Examination Survey 2011-2012. Fertil Steril. 2015;103(1):172–8. doi:10.1016/j.fertnstert.2014.09.020.

Vyskocil A, Viau C. Assessment of molybdenum toxicity in humans. J Appl Toxicol. 1999;19(3):185–92.doi:10.1002/(SICI)1099-1263(199905/06)19:3<185:AID-JAT555>3.0.CO;2-Z.

Gorbachev AL, Skalny AV, Koubassov RV. Bioelement effects on thyroid gland in children living in iodine-adequate territory. J Trace Elem Med Biol. 2007;21 Suppl 1:56–8. doi:10.1016/j.jtemb.2007.09.026.

Veldanova MV, Skalny AV. The effectiveness of endemic goiter treatment depends on some trace elements metabolism balance in humans. In: Abstracts of 11th. International Symposium on Trace Elements in Man and Animals (TEMA-11); 2-6 June 2002; Berkley, California, USA. Berkley: p. 82.

Portulano C, Paroder-Belenitsky M, Carrasco N. The Na+/I- symporter (NIS): mechanism and medical impact. Endocr Rev. 2014;35(1):106–49. doi:10.1210/er.2012-1036.

Syed S. Iodine and the “near” eradication of cretinism. Pediatrics. 2015;135(4):594–6. doi:10.1542/peds.2014-3718.

Ghirri P, Lunardi S, Boldrini A. Iodine supplementation in the newborn. Nutrients. 2014;6(1):382–90. doi:10.3390/nu6010382.

Roti E, Uberti ED. Iodine excess and hyperthyroidism. Thyroid. 2001;11(5):493–500. doi:10.1089/105072501300176453.

World Health Organization. Urinary Iodine Concentrations for Determining Iodine Status in Populations. (24.10.2024 tarihinde https://iris.who.int/bitstream/handle/10665/85972/WHO_NMH_NHD_EPG_13.1_eng.pdf adresinden ulaşılmıştır).

Veldanova MV, Skalny AV. The comparison of ioduria, hair iodine and other trace elements concentration data in children living in different regions of Russia. In: Proceedings of 3rd International Symposium on Trace Elements in Human: New Perspectives; 4-6 October 2001; Athens, Greece. Athens; p. 522–8.

del Ghianda S, Tonacchera M, Vitti P. Thyroid and menopause. Climacteric. 2014;17(3):225–34. doi:10.3109/13697137.2013.838554.

Eng PH, Cardona GR, Previti MC, et al. Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol. 2001;144(2):139–44. doi:10.1530/eje.0.1440139.

Nicola JP, Reyna-Neyra A, Carrasco N, et al. Dietary iodide controls its own absorption through post-transcriptional regulation of the intestinal Na+/I- symporter. J Physiol. 2012;590(23):6013–26. doi:10.1113/jphysiol.2012.241307.

Gurgul E, Kasprzak A, Blaszczyk A, et al. Ghrelin and obestatin in thyroid gland - immunohistochemical expression in nodular goiter, papillary and medullary cancer. Folia Histochem Cytobiol. 2015;53(1):19–25. doi:10.5603/FHC.a2015.0004.

Adamczewska K, Adamczewski Z, Łupińska A, et al. trong positive correlation between TSH and ghrelin in euthyroid non-growth hormone-deficient children with short stature. Molecules (Basel, Switzerland). 2020;25(17):3912. doi:10.3390/molecules25173912.

Smanik PA, Ryu KY, Theil KS, et al. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology. 1997;138(8):3555–8. doi:10.1210/endo.138.8.5262.

Fong P. Thyroid iodide efflux: a team effort?. J Physiol. 2011;589(Pt 24):5929–39. doi:10.1113/jphysiol.2011.218594.

Alotaibi H, Tuzlakoğlu-Öztürk M, Tazebay UH. The thyroid Na+/I- symporter: molecular characterization and genomic regulation. Molecular Imaging and Radionuclide Therapy. 2017;26(Suppl 1):92–101. doi:10.4274/2017.26.suppl.11.

Riedel C, Levy O, Carrasco N. Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem. 2001;276(24):21458–63. doi:10.1074/jbc.M100561200.

Cavalieri RR. Iodine metabolism and thyroid physiology: current concepts. Thyroid. 1997;7(2):177–81. doi:10.1089/thy.1997.7.177.

Pesce L, Bizhanova A, Caraballo JC, et al. TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells. Endocrinology. 2012;153(1):512–21. doi:10.1210/en.2011-1548.

Bizhanova A, Kopp P. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology. 2009;150(3):1084–90. doi:10.1210/en.2008-1437.

Bizhanova A, Kopp P. Genetics and phenomics of Pendred syndrome. Mol Cell Endocrinol. 2010;322(1-2):83–90. doi:10.1016/j.mce.2010.03.006.

Senou M, Khalifa C, Thimmesch M, et al. A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the Pendred thyroid. J Clin Endocrinol Metab. 2010;95(8):4021–30. doi:10.1210/jc.2010-0228.

Leung AM, Pearce EN, Braverman LE. Perchlorate, iodine and the thyroid. Best Pract Res Clin Endocrinol Metab. 2010;24(1):133–41. doi:10.1016/j.beem.2009.08.009.

Rousset B, Dupuy C, Miot F, et al. Chapter 2 Thyroid hormone synthesis and secretion. In: Feingold KR, editor. Endotext. MDText.com, Inc; 2015.

Rillema JA, Yu TX, Jhiang SM. Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants. Am J Physiol Endocrinol Metab. 2000;279(4)–E772. doi:10.1152/ajpendo.2000.279.4.E769.

Burns R, O’Herlihy C, Smyth PP. Regulation of iodide uptake in placental primary cultures. Eur Thyroid J. 2013;2(4):243–51. doi:10.1159/000356847.

Bowden SA, Goldis M. Congenital Hypothyroidism. (Updated 2023 Jun 5). In: StatPearls Treasure Island (FL): StatPearls Publishing; 2024 Jan-. (14.10.2024 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK558913/ adresinden ulaşılmıştır).

Prete A, Paragliola RM, Corsello SM. Iodine supplementation: usage “with a grain of salt”. Int J Endocrinol. 2015;2015:312305. doi:10.1155/2015/312305.

Velasco I, Rueda-Etxebarria M, Trak-Fellermeier MA, et al. Iodine supplementation for preventing iodine deficiency disorders in children and adolescents. Cochrane Database Syst Rev. 2023;2023(4). doi:10.1002/14651858.CD014475.

Li JH, He ZH, Bansal V, et al. Low iodine diet in differentiated thyroid cancer: a review. Clin Endocrinol. 2016;84(1):3–12. doi:10.1111/cen.12846.

Zeng Z, Li K, Kang W, et al. Changing patterns of thyroid cancer in different stages of Universal Salt Iodization in Peking Union Medical College Hospital, 1986-2018. Gland Surg. 2020;9(5):1338–45. doi:10.21037/gs-20-346.

Ward LS, Santarosa PL, Granja F, et al. Low expression of sodium iodide symporter identifies aggressive thyroid tumors. Cancer Lett. 2003;200(1):85–91. doi:10.1016/s0304-3835(03)00392-6.

Wei S, Gao M, Zhao C, et al. Low expression of sodium iodide symporter in aggressive variants of papillary thyroid carcinoma. Int J Clin Oncol. 2014;19(5):800–4. doi:10.1007/s10147-013-0620-z.

Xu S, Chen G, Peng W, et al. Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules? J Endocrinol. 2013;218(1):125–33. doi:10.1530/JOE-13-0029.

Chatterjee S, Malhotra R, Varghese F, et al. Quantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer. PLoS One. 2013;8(1). doi:10.1371/journal.pone.0054055.

Kazi TG, Kandhro GA, Afridi HI, et al. Interaction of copper with iron, iodine, and thyroid hormone status in goitrous patients. Biol Trace Elem Res. 2010;134(3):265–79. doi:10.1007/s12011-009-8478-7.

Skalny AV. Bioelementology as an interdisciplinary integrative approach in life sciences: terminology, classification, perspectives. J Trace Elem Med Biol. 2011;25 Suppl 1–10. doi:10.1016/j.jtemb.2010.10.05.

Santamaria AB. Manganese exposure, essentiality, and toxicity. Indian J Med Res. 2008;128(4):484–500.

Friedman BJ, Freeland-Graves JH, Bales CW, et al. Manganese balance and clinical observations in young men fed a manganese-deficient diet. J Nutr. 1987;117(1):133–43. doi:10.1093/jn/117.1.133.

Aschner M, Erikson KM, Dorman DC. Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol. 2005;35(1):1–32. doi:10.1080/10408440590905920.

Bai SP, Lu L, Wang RL, et al. Manganese source affects manganese transport and gene expression of divalent metal transporter 1 in the small intestine of broilers. Br J Nutr. 2012;108(2):267–76. doi:10.1017/S0007114511005629.

Garrick MD, Dolan KG, Horbinski C, et al. DMT1: a mammalian transporter for multiple metals. Biometals. 2003;16(1):41–54. doi:10.1023/a:1020702213099.

Yin Z, Jiang H, Lee ES, et al. Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J Neurochem. 2010;112(5):1190–8. doi:10.1111/j.1471-4159.2009.06534.x.

Madejczyk MS, Ballatori N. The iron transporter ferroportin can also function as a manganese exporter. Biochim Biophys Acta. 2012;1818(3):651–7. doi:10.1016/j.bbamem.2011.12.002.

Finley JW, Davis CD. Manganese deficiency and toxicity: are high or low dietary amounts of manganese cause for concern? BioFactors (Oxford). 1999;10(1):15–24. doi:10.1002/biof.5520100102.

Mukhopadhyay S, Linstedt AD. Identification of a gain-of-function mutation in a Golgi P-type ATPase that enhances Mn²⁺ efflux and protects against toxicity. Proc Natl Acad Sci U S A. 2011;108(2):858–63. doi:10.1073/pnas.1013642108.

Culotta VC, Yang M, Hall MD. Manganese transport and trafficking: lessons learned from Saccharomyces cerevisiae. Eukaryot Cell. 2005;4(7):1159–65. doi:10.1128/EC.4.7.1159-1165.2005.

He W, Hu Z. The role of the Golgi-resident SPCA Ca²⁺/Mn²⁺ pump in ionic homeostasis and neural function. Neurochem Res. 2012;37(3):455–68. doi:10.1007/s11064-011-0644-6.

Tuschl K, Mills PB, Clayton PT. Manganese and the brain. Int Rev Neurobiol. 2013;110:277–312. doi:10.1016/B978-0-12-410502-7.00013-2.

Zheng G, Chen J, Zheng W. Relative contribution of CTR1 and DMT1 in copper transport by the blood-CSF barrier: implication in manganese-induced neurotoxicity. Toxicol Appl Pharmacol. 2012;260(3):285–93. doi:10.1016/j.taap.2012.03.006.

Tuschl K, Clayton PT, Gospe SM Jr, et al. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am J Hum Genet. 2012;90(3):457–66. doi:10.1016/j.ajhg.2012.01.018.

Soldin OP, Aschner M. Effects of manganese on thyroid hormone homeostasis: potential links. Neurotoxicology. 2007;28(5):951–6. doi:10.1016/j.neuro.2007.05.003.

Ilies M, Di Costanzo L, North ML, et al. 2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I. J Med Chem. 2010;53(10):4266–76. doi:10.1021/jm100306a.

Kalea AZ, Harris PD, Klimis-Zacas DJ. Dietary manganese suppresses alpha1 adrenergic receptor-mediated vascular contraction. J Nutr Biochem. 2005;16(1):44–9. doi:10.1016/j.jnutbio.2004.09.002.

Nordhoy W, Anthonsen HW, Bruvold M, et al. Manganese ions as intracellular contrast agents: proton relaxation and calcium interactions in rat myocardium. NMR Biomed. 2003;16(2):82–95. doi:10.1002/nbm.817.

Perry CA, Taylor JF, Nunn A, et al. Perthes’ disease and blood manganese levels. Arch Dis Child. 2000;82(5):428. doi:10.1136/adc.82.5.428f.

Semikopenko VA, Skalny AV, Karpukhin AV. The pilot study of trace element specialities and genetic mutations in breast cancer patients. In: Abstracts of 2nd International FESTEM Symposium on Trace Elements and Minerals in Medicine and Biology; May 13–15, 2004; Munich, Germany. Munich: p.105.

Dhar SK, Tangpong J, Chaiswing L, et al. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages. Cancer Res. 2011;71(21):6684–95. doi:10.1158/0008-5472.CAN-11-1233.

Holley AK, Dhar SK, Xu Y, et al. Manganese superoxide dismutase: beyond life and death. Amino Acids. 2012;42(1):139–58. doi:10.1007/s00726-010-0600-9.

Cai Q, Shu XO, Wen W, et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res. 2004;6(6)–55. doi:10.1186/bcr929.

Liu G, Sun G, Wang Y, et al. Association between manganese superoxide dismutase gene polymorphism and breast cancer risk: a meta-analysis of 17,842 subjects. Mol Med Rep. 2012;6(4):797–804. doi:10.3892/mmr.2012.998.

Hart PC, Mao M, de Abreu AL, et al. MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat Commun. 2015;6:6053. doi:10.1038/ncomms7053.

Kattan Z, Minig V, Leroy P, et al. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res Treat. 2008;108(2):203–15. doi:10.1007/s10549-007-9597-5.

Matsuoka A, Kizuka F, Lee L, et al. Progesterone increases manganese superoxide dismutase expression via a cAMP-dependent signaling mediated by noncanonical Wnt5a pathway in human endometrial stromal cells. J Clin Endocrinol Metab. 2010;95(11)–9. doi:10.1210/jc.2010-0619.

Sugino N, Takiguchi S, Kashida S, et al. Superoxide dismutase expression in the human corpus luteum during the menstrual cycle and in early pregnancy. Mol Hum Reprod. 2000;6(1):19–25. doi:10.1093/molehr/6.1.19.

Sugino N, Hirosawa-Takamori M, Zhong L, et al. Hormonal regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase messenger ribonucleic acid in the rat corpus luteum: induction by prolactin and placental lactogens. Biol Reprod. 1998;59(3):599–605. doi:10.1095/biolreprod59.3.599.

Unfer TC, Figueiredo CG, Zanchi MM, et al. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women. Climacteric. 2015;18(3):379–88. doi:10.3109/13697137.2014.964669.

Porcheron G, Garénaux A, Proulx J, et al. Iron, copper, zinc, and manganese transport and regulation in pathogenic Enterobacteria: correlations between strains, site of infection and the relative importance of the different metal transport systems for virulence. Front Cell Infect Microbiol. 2013;3:90. doi:10.3389/fcimb.2013.00090.

Lisher JP, Giedroc DP. Manganese acquisition and homeostasis at the host-pathogen interface. Front Cell Infect Microbiol. 2013;3:91. doi:10.3389/fcimb.2013.00091.

Just N, Cudalbu C, Lei H, et al. Effect of manganese chloride on the neurochemical profile of the rat hypothalamus. J Cereb Blood Flow Metab. 2011;31(12):2324–33. doi:10.1038/jcbfm.2011.92.

Rodríguez-Rodríguez E, Bermejo LM, López-Sobaler AM, et al. Una ingesta inadecuada de manganeso podría contribuir a la aparición de resistencia a la insulina en niñas [An inadequate intake of manganese may favour insulin resistance in girls]. Nutrición Hospitalaria. 2011;26(5):965–70. doi:10.1590/S0212-16112011000500007.

Baly DL, Keen CL, Hurley LS. Pyruvate carboxylase and phosphoenolpyruvate carboxykinase activity in developing rats: effect of manganese deficiency. J Nutr. 1985;115(7):872–9. doi:10.1093/jn/115.7.872.

Matyal R, Sakamuri S, Huang T, et al. Oxidative stress and nerve function after cardiopulmonary bypass in patients with diabetes. Ann Thorac Surg. 2014;98(5):1635–44. doi:10.1016/j.athoracsur.2014.06.041.

Besio R, Baratto MC, Gioia R, et al. A Mn(II)-Mn(II) center in human prolidase. Biochim Biophys Acta. 2013;1834(1):197–204. doi:10.1016/j.bbapap.2012.09.008.

Cheng J, Fu JL, Zhou ZC. The inhibitory effects of manganese on steroidogenesis in rat primary Leydig cells by disrupting steroidogenic acute regulatory (StAR) protein expression. Toxicology. 2003;187(2-3):139–48. doi:10.1016/s0300-483x(03)00063-5.

Skalnaya MG, Serebryansky EP, Yurasov VV, et al. Association between semen quality and level of 20 essential and toxic metals in ejaculate. Trace Elem Electrolytes. 2015;32(3):126–32. doi:10.5414/TEX01378.

Takeda A. Manganese action in brain function. Brain Res Brain Res Rev. 2003;41(1):79–87. doi:10.1016/s0165-0173(02)00234-5.

Carl GF, Blackwell LK, Barnett FC, et al. Manganese and epilepsy: brain glutamine synthetase and liver arginase activities in genetically epilepsy prone and chronically seizured rats. Epilepsia. 1993;34(3):441–6. doi:10.1111/j.1528-1157.1993.tb02584.x.

Hamberg M, Su C, Oliw E. Manganese lipoxygenase. Discovery of a bis-allylic hydroperoxide as product and intermediate in a lipoxygenase reaction. J Biol Chem. 1998;273(21):13080–8. doi:10.1074/jbc.273.21.13080.

Furukawa K, Okajima T. Galactosyltransferase I is a gene responsible for progeroid variant of Ehlers-Danlos syndrome: molecular cloning and identification of mutations. Biochim Biophys Acta. 2002;1573(3):377–81. doi:10.1016/s0304-4165(02)00406-3.

Kimura M, Ujihara M, Yokoi K. Tissue manganese levels and liver pyruvate carboxylase activity in magnesium-deficient rats. Biol Trace Elem Res. 1996;52(2):171–9. doi:10.1007/BF02789459.

Kim Y, Lobdell DT, Wright CW, et al. Blood metal concentrations of manganese, lead, and cadmium in relation to serum ferritin levels in Ohio residents. Biol Trace Elem Res. 2015;165(1):1–9. doi:10.1007/s12011-014-0223-1.

Lee BK, Kim Y. Effects of menopause on blood manganese levels in women: analysis of 2008-2009 Korean National Health and Nutrition Examination Survey data. Neurotoxicology. 2012;33(3):401–5. doi:10.1016/j.neuro.2012.04.015.

Lee BK, Kim Y. Sex-specific profiles of blood metal levels associated with metal-iron interactions. Saf Health Work. 2014;5(3):113–7. doi:10.1016/j.shaw.2014.06.005.

Carlisle EM. Silicon. In: Mertz W, ed. Trace elements in human and animal nutrition. 5th ed. Vol. 2. Orlando: Academic Press; 1986. p. 373–90. doi:10.1016/B978-0-08-092469-4.50011-X.

Schwarz K. Significance and functions of silicon in warm-blooded animals. Review and outlook. In: Bendz G, Lindqvist I, Runnström-Reio V, editors. Biochemistry of Silicon and Related Problems. Nobel Foundation Symposia, vol 40. Boston: Springer; 1978. p. 169–76. doi:10.1007/978-1-4613-4018-8_9.

Jugdaohsingh R, Anderson SH, Tucker KL, et al. Dietary silicon intake and absorption. Am J Clin Nutr. 2002;75(5):887–93. doi:10.1093/ajcn/75.5.887.

Jugdaohsingh R. Silicon and bone health. J Nutr Health Aging. 2007;11(2):99–110.

Martin KR. The chemistry of silica and its potential health benefits. J Nutr Health Aging. 2007;11(2):94–7.

Nakanishi L, Bombonatti B, Muller LS, et al. Oral supplementation of orthosilicic acid and its impact on hair quality. Med Cut Iber Lat Am. 2017;45:29–35.

Carlisle EM. Silicon: a possible factor in bone calcification. Science. 1970;167(3916):279–80. doi:10.1126/science.167.3916.279.

Birchall JD, Bellia JP, Roberts NB. On the mechanisms underlying the essentiality of silicon—interactions with aluminium and copper. Coord Chem Rev. 1996;149:231–40. doi:10.1016/S0010-8545(96)90028-4.

Loeper J, Loeper J, Fragny M. The physiological role of the silicon and its antiatheromatous action. In: Bendz G, Lindqvist I, Runnström-Reio V, editors. Biochemistry of Silicon and Related Problems. Boston: Springer US; 1978. p. 281–96.

National Research Council (NRC). Geochemistry and the Environment: Volume II: The Relation of Other Selected Trace Elements to Health and Disease. Washington, DC: The National Academies Press; 1977. doi:10.17226/19929.

Herring LC. Observations on the analysis of ten thousand urinary calculi. J Urol. 1962;88:545–62. doi:10.1016/S0022-5347(17)64842-0.

Sunderman FW Jr. Sources of exposure and biological effects of nickel exposure. In: IARC Monographs on Environmental Carcinogens – Selected Methods of Analysis, Vol. 8. Lyon: IARC; 1986. p. 79–92.

Veien N, Andersen M. Nickel in Danish food. Acta Derm Venereol. 1986;66(6):502–9. doi:10.2340/0001555566502509.

Sydor AM, Zamble DB. Nickel metallomics: general themes guiding nickel homeostasis. In: Sigel A, Sigel H, editors. Metal Ions in Life Sciences. Vol. 12. Dordrecht: Springer; 2013. p. 375–416. doi:10.1007/978-94-007-5561-1_11.

Hostynek JJ, Maibach HI, Maibach HI, editors. Nickel and the Skin: Absorption, Immunology, Epidemiology, and Metallurgy. 1st ed. Boca Raton: CRC Press; 2002. p. 1–249. doi:10.1201/b14242.

Goldbach HE, Wimmer MA. Boron in plants and animals: is there a role beyond cell-wall structure? J Plant Nutr Soil Sci. 2007;170(1):39–48. doi:10.1002/jpln.200625161.

Nielsen FH. Boron, manganese, molybdenum and other trace elements. In: Bowman BA, Russell RM, editors. Present Knowledge in Nutrition. 8th ed. Washington DC: ILSI Press; 2001. p. 384–400.

Hunt CD. Regulation of enzymatic activity: one possible role of dietary boron in higher animals and humans. Biol Trace Elem Res. 1998;66(1-3):205–25. doi:10.1007/BF02783139.

Tanaka M, Fujiwara T. Physiological roles and transport mechanisms of boron: perspectives from plants. Pflugers Arch Eur J Physiol. 2008;456(4):671–7. doi:10.1007/s00424-007-0370-8.

Ku WW, Chapin RE, Moseman RF, et al. Tissue disposition of boron in male Fischer rats. Toxicol Appl Pharmacol. 1991;111(1):145–51. doi:10.1016/0041-008x(91)90143-3.

Baker SJ, Tomsho JW, Benkovic SJ. Boron-containing inhibitors of synthetases. Chem Soc Rev. 2011;40(8):4279–85. doi:10.1039/c0cs00131g.

Duydu Y, Başaran N, Bolt HM. Exposure assessment of boron in Bandırma boric acid production plant. J Trace Elem Med Biol. 2012;26(2-3):161–4. doi:10.1016/j.jtemb.2012.03.008.

Litovitz TL, Klein-Schwartz W, Oderda GM, et al. Clinical manifestations of toxicity in a series of 784 boric acid ingestions. Am J Emerg Med. 1988;6(3):209–13. doi:10.1016/0735-6757(88)90001-0.

Nielsen FH. Boron in human and animal nutrition. Plant Soil. 1997;193(1):199–208.

Murray FJ. A human health risk assessment of boron (boric acid and borax) in drinking water. Regul Toxicol Pharmacol. 1995;22(3):221–30. doi:10.1006/rtph.1995.0004.

Penland JG. The importance of boron nutrition for brain and psychological function. Biol Trace Elem Res. 1998;66(1-3):299–317. doi:10.1007/BF02783144.

Peng X, Lingxia Z, Schrauzer GN, et al. Selenium, boron, and germanium deficiency in the etiology of Kashin-Beck disease. Biol Trace Elem Res. 2000;77(3):193–7. doi:10.1385/BTER:77:3:193.

Fort DJ, Stover EL, Strong PL, et al. Chronic feeding of a low boron diet adversely affects reproduction and development in Xenopus laevis. J Nutr. 1999;129(11):2055–60. doi:10.1093/jn/129.11.2055.

Eckhert CD, Rowe RI. Embryonic dysplasia and adult retinal dystrophy in boron‐deficient zebrafish. J Trace Elem Exp Med. 1999;12(3):213–9.

Lanoue L, Taubeneck MW, Muniz J, et al. Assessing the effects of low boron diets on embryonic and fetal development in rodents using in vitro and in vivo model systems. Biol Trace Elem Res. 1998;66(1-3):271–98. doi:10.1007/BF02783143.

Nielsen FH. Evidence for the nutritional essentiality of boron. J Trace Elem Exp Med. 1996;9(4):215–9.

Hunt CD, Idso JP. Dietary boron as a physiological regulator of the normal inflammatory response: a review and current research progress. J Trace Elem Exp Med. 1999;12(3):221–33.

Rehder D. The role of vanadium in biology. Metallomics. 2015;7(5):730–42. doi:10.1039/c4mt00304g.

Rehder D. Perspectives for vanadium in health issues. Future Med Chem. 2016;8(3):325–38. doi:10.4155/fmc.15.187.

Agency for Toxic Substance and Disease Registry (ATSDR). Toxicological Profile for Vanadium. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control; 2012. (15.10.2024 tarihinde https://www.atsdr.cdc.gov/toxprofiles/tp58.pdf. adresinden ulaşılmıştır).

Levina A, McLeod AI, Kremer LE, et al. Reactivity-activity relationships of oral anti-diabetic vanadium complexes in gastrointestinal media: an X-ray absorption spectroscopic study. Metallomics. 2014;6(10):1880–8. doi:10.1039/c4mt00146j.

Frieden E. Biochemistry of the essential ultratrace elements. New York: Plenum Press; 1984. 444 p. doi:10.1007/978-1-4684-4775-0.

Hopkins LL Jr, Mohr HE. Proceedings: Vanadium as an essential nutrient. Fed Proc. 1974;33(6):1773–5.

Ramasarma T, Crane FL. Does vanadium play a role in cellular regulation? In: Current topics in cellular regulation. Vol 20. London: Academic Press; 1981. p. 247–301. doi:10.1016/b978-0-12-152820-1.50011-0.

Li H, Zhou D, Zhang Q, et al. Vanadium exposure-induced neurobehavioral alterations among Chinese workers. Neurotoxicology. 2013;36:49–54. doi:10.1016/j.neuro.2013.02.008.

Ma J, Pan LB, Wang Q, et al. Estimation of the daily soil/dust (SD) ingestion rate of children from Gansu Province, China via hand-to-mouth contact using tracer elements. Environ Geochem Health. 2018;40(1):295–301. doi:10.1007/s10653-016-9906-1.

Masironi R. Trace elements and cardiovascular diseases. Bull World Health Organ. 1969;40(2):305–12.

Stamp TC. Fluoride. In: Macrae R, Robinson RK, Sadler MJ, editors. Encyclopaedia of Food Science, Food Technology and Nutrition. London: Academic Press; 1993. p. 1932.

National Research Council, Commission on Life Sciences, & Subcommittee on the Tenth Edition of the Recommended Dietary Allowances. Recommended Dietary Allowances. Washington, DC: National Academies Press (US); 1989. 302 p.

National Research Council. Fluoride in Drinking Water: A Scientific Review of EPA’s Standards. Washington, DC: The National Academies Press; 2006. (03.11.2024 tarihinde https://doi.org/10.17226/11571. adresinden ulaşılmıştır).

Bagga OP, Mehta SP, Parkash V, et al. Urinary fluoride excretion in endemic fluorosis. Fluoride. 1979;12(2):72–75. (03.11.2024 tarihinde https://www.fluorideresearch.online/122/files/FJ1979_v12_n2_p055-110.pdf. adresinden ulaşılmıştır).

Rubin R, Strayer DS, Rubin E, editors. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1341.

Satoskar RS, Bhandarkar SD, Alnapure SS. Pharmacology and Pharmacotherapeutics. 6th ed. Mumbai: Popular Prakashan; 1999. p. 1012–1013.

Satoskar RS, Bhandarkar SD. Pharmacology and Pharmacotherapeutics. New Delhi: Elsevier India; 2020.

Alexander BH, Checkoway H, van Netten C, et al. Semen quality of men employed at a lead smelter. Occup Environ Med. 1996;53(6):411–16. doi:10.1136/oem.53.6.411.

Wigle DT. Child Health and the Environment. Oxford: Oxford University Press; 2003. 396 p.

Arruda-Neto JD, de Oliveira MC, Sarkis JE, et al. Study of environmental burden of lead in children using teeth as bioindicator. Environ Int. 2009;35(3):614–18. doi:10.1016/j.envint.2008.12.005.

Lansdown R, Yule W. Lead toxicity: History and environmental impact. Johns Hopkins University Press, Baltimore, MD, USA; 1986. p. 51–95.

Aliasgharpour M, Abbassi M. The absence of hematological outcome in workers occupationally exposed to lead in Tehran-Iran. Haema. 2006;9:398–400.

Cooper RL, Goldman JM, Rehnberg GL. Pituitary function following treatment with reproductive toxins. Environ Health Perspect. 1986;70:177–84. doi:10.1289/ehp.8670177.

Coffigny H, Thoreux-Manlay A, Pinon-Lataillade G, et al. Effects of lead poisoning of rats during pregnancy on the reproductive system and fertility of their offspring. Hum Exp Toxicol. 1994;13(4):241–6. doi:10.1177/096032719401300403.

Chia SE, Ong CN, Lee ST, et al. Blood concentrations of lead, cadmium, mercury, zinc, and copper and human semen parameters. Arch Androl. 1992;29(2):177–83. doi:10.3109/01485019208987722.

Meeker JD, Rossano MG, Protas B, et al. Cadmium, lead, and other metals in relation to semen quality: human evidence for molybdenum as a male reproductive toxicant. Environ Health Perspect. 2008;116(11):1473–9. doi:10.1289/ehp.11490.

Telisman S, Colak B, Pizent A, et al. Reproductive toxicity of low-level lead exposure in men. Environ Res. 2007;105(2):256–66. doi:10.1016/j.envres.2007.05.011.

Mehri A. Trace elements in human nutrition (II) - An update. Int J Prev Med. 2020;11:2. doi:10.4103/ijpvm.IJPVM_48_19.

Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for cadmium. 2012 (03.11.2024 tarihinde https://www.atsdr.cdc.gov/. adresinden ulaşılmıştır).

Figueiredo-Pereira ME, Yakushin S, Cohen G. Disruption of the intracellular sulfhydryl homeostasis by cadmium-induced oxidative stress leads to protein thiolation and ubiquitination in neuronal cells. J Biol Chem. 1998;273(21):12703–9. doi:10.1074/jbc.273.21.12703.

Asagba SO, Eriyamremu GE, Adaikpoh MA, et al. Levels of lipid peroxidation, superoxide dismutase, and Na+/K+ ATPase in some tissues of rats exposed to a Nigerian-like diet and cadmium. Biol Trace Elem Res. 2004;100(1):75–86. doi:10.1385/BTER:100:1:075.

Asagba SO, Obi FO. A comparative evaluation of the biological effects of environmental cadmium-contaminated control diet and laboratory-cadmium supplemented test diet. Biometals. 2005;18(2):155–61. doi:10.1007/s10534-004-4257-2.

Gałazyn-Sidorczuk M, Brzóska MM, Jurczuk M, et al. Oxidative damage to proteins and DNA in rats exposed to cadmium and/or ethanol. Chem Biol Interact. 2009;180(1):31–8. doi:10.1016/j.cbi.2009.01.014.

Sarkar S, Yadav P, Trivedi R, et al. Cadmium-induced lipid peroxidation and the status of the antioxidant system in rat tissues. J Trace Elem Med Biol. 1995;9(3):144–9. doi:10.1016/S0946-672X(11)80038-6.

Asagba SO, Isamah GK, Ossai EK, et al. Effect of oral exposure to cadmium on the levels of vitamin A and lipid peroxidation in the eye. Bull Environ Contam Toxicol. 2002;68(1):18–21. doi:10.1007/s00128-001-0213-9.

Verschoor M, Herber R, van Hemmen J, et al. Renal function of workers with low-level cadmium exposure. Scand J Work Environ Health. 1987;13(3):232–8. doi:10.5271/sjweh.2065.

Roels HA, Lauwerys RR, Buchet JP, et al. Health significance of cadmium induced renal dysfunction: a five year follow up. Br J Ind Med. 1989;46(11):755–64. doi:10.1136/oem.46.11.755.

Staessen J, Amery A, Bernard A, et al. ffects of exposure to cadmium on calcium metabolism: a population study. Br J Ind Med. 1991;48(10):710–4. doi:10.1136/oem.48.10.710.

Staessen JA, Vyncke G, Lauwerys RR, et al. Transfer of cadmium from a sandy acidic soil to man: a population study. Environ Res. 1992;58(1):25–34. doi:10.1016/s0013-9351(05)80202-6.

Sartor FA, Rondia DJ, Claeys FD, et al. Impact of environmental cadmium pollution on cadmium exposure and body burden. Arch Environ Health. 1992;47(5):347–53. doi:10.1080/00039896.1992.9938373.

Leroy A, Hemon D, Nisse C, et al. Determinants of cadmium burden levels in a population of children living in the vicinity of nonferrous smelters. Environ Res. 2001;87(3):147–59. doi:10.1006/enrs.2001.4300.

Stoeppler M, Piscator M, editors. Cadmium. 3rd IUPAC Cadmium Workshop, Juelich, FRG, August 1985. Springer, Berlin, Germany; 1988. p. 237. doi:10.1007/978-3-642-70553-3.

Glaser U, editor. Cadmium. Proceedings of the 4th IUPAC Workshop. Toxicol Environ Chem. 1990;27:1–196.

Leroy A, Hemon D, Nisse C, et al. Determinants of cadmium burden levels in a population of children living in the vicinity of nonferrous smelters. Environ Res. 2001;87(3):147–59. doi:10.1006/enrs.2001.4300.

Nordberg G, Herber RF, Alessio L, editors. Cadmium in the Human Environment: Toxicity and Carcinogenicity. International Agency for Research on Cancer, Lyon, France; 1992. IARC Scientific Publications No. 118.

Kobayashi E, Okubo Y, Suwazono Y, et al. Dose-response relationship between total cadmium intake calculated from the cadmium concentration in rice collected from each household of farmers and renal dysfunction in inhabitants of the Jinzu River basin, Japan. J Appl Toxicol. 2002;22(6):431–6. doi:10.1002/jat.882.

Alfvén T, Järup L, Elinder CG. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect. 2002;110(7):699–702. doi:10.1289/ehp.110-1240916.

Nordberg G, Jin T, Bernard A, et al. Low bone density and renal dysfunction following environmental cadmium exposure in China. Ambio. 2002;31(6):478–81. doi:10.1579/0044-7447-31.6.478.

Hellström L, Elinder CG, Dahlberg B, et al. Cadmium exposure and end-stage renal disease. Am J Kidney Dis. 2001;38(5):1001–8. doi:10.1053/ajkd.2001.28589.

Hotz P, Buchet JP, Bernard A, et al. Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study. Lancet. 1999;354(9189):1508–13. doi:10.1016/s0140-6736(99)91145-5.

Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Mercury; 1999. (24.10.2024 tarihinde https://www.atsdr.cdc.gov/. adresinden ulaşılmıştır).

Muttera J, Curth A, Naumann J, et al. Does inorganic mercury play a role in Alzheimer’s disease? A systematic review and an integrated molecular mechanism. J Alzheimer’s Dis. 2010;22(2):357–74. doi:10.3233/JAD-2010-100705.

Bjørklund G, Dadar M, Mutter J, et al. The toxicology of mercury: Current research and emerging trends. Environ Res. 2017;159:545–54. doi:10.1016/j.envres.2017.08.051.

Klotz K, Weistenhöfer W, Neff F, et al. The health effects of aluminum exposure. Dtsch Arztebl Int. 2017;114(39):653–9. doi:10.3238/arztebl.2017.0653.

Nieboer E, Gibson BL, Oxman AD, et al. Health effects of aluminum: a critical review with emphasis on aluminum in drinking water. Environ Rev. 1995;3(1):29–81. (24.10.2024 tarihinde http://www.jstor.org/stable/envirevi.3.1.29. adresinden ulaşılmıştır).

Yokel RA. The toxicology of aluminum in the brain: a review. Neurotoxicology. 2000;21(5):813–28.

Alfrey AC, LeGendre GR, Kaehny WD. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976;294(4):184–8. doi:10.1056/NEJM197601222940402.

Reusche E. Argyrophilic inclusions distinct from Alzheimer neurofibrillary changes in one case of dialysis-associated encephalopathy. Acta Neuropathol. 1997;94(6):612–6. doi:10.1007/s004010050757.

Berend K, Voet GB, Wolff FA. Acute aluminum intoxication. In: Roesky HW, Atwood DA, eds. Group 13 Chemistry II – Biological Aspects of Aluminum. Berlin: Springer-Verlag; 2002. p. 1–58.

Phelps KR, Naylor K, Brien TP, et al. Encephalopathy after bladder irrigation with alum: case report and literature review. Am J Med Sci. 1999;318(3):181–5. doi:10.1097/00000441-199909000-00013.

Reusche E, Pilz P, Oberascher G, et al. Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: a case report. Hum Pathol. 2001;32(10):1136–40. doi:10.1053/hupa.2001.28251.

McLachlan DRC. Aluminum and the risk for Alzheimer’s disease. Environmetrics. 1995;6:233–75.

Szutowicz A. Aluminum neurotoxicity. In: Massaro EJ, ed. Handbook of Neurotoxicology. Totowa, NJ: Humana Press Inc; 2002. p. 211–36.

Polizzi S, Pira E, Ferrara M, et al. Neurotoxic effects of aluminum among foundry workers and Alzheimer’s disease. Neurotoxicology. 2002;23(6):761–74. doi:10.1016/S0161-813X(02)00097-9.

Lotz M, Zisman E, Bartter FC. Evidence for a phosphorus-depletion syndrome in man. N Engl J Med. 1968;278(8):409–15. doi:10.1056/NEJM196802222780802.

Exley C. A molecular mechanism of aluminium-induced Alzheimer’s disease? J Inorg Biochem. 1999;76(2):133–40. doi:10.1016/s0162-0134(99)00125-7.

Nasiadek M, Chmielnicka J, Subdys J. Analysis of urinary porphyrins in rats exposed to aluminum and iron. Ecotoxicol Environ Saf. 2001;48(1):11–7. doi:10.1006/eesa.2000.1999.

Pérez G, Garbossa G, Di Risio C, et al. Disturbance of cellular iron uptake and utilisation by aluminium. J Inorg Biochem. 2001;87(1-2):21–7. doi:10.1016/s0162-0134(01)00310-5.

Agency for Toxic Substances and Disease Registry (ATSDR). Health consultation, blood and urine tests. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control. Atlanta, GA; 2004. (24.10.2024 tarihinde https://www.atsdr.cdc.gov/HAC/pha/BloodUrineTestResults051104FL/BloodUrineTestResultsHC051104. adresinden ulaşılmıştır).

World Health Organization (WHO). Fact sheet on Arsenic. (24.10.2024 tarihinde https://www.who.int/news-room/fact-sheets/detail/arsenic. adresinden ulaşılmıştır).

Quansah R, Armah FA, Essumang DK, et al. Association of arsenic with adverse pregnancy outcomes/infant mortality: a systematic review and meta-analysis. Environ Health Perspect. 2015;123(5):412–21. doi:10.1289/ehp.1307894.

Farzan SF, Karagas MR, Chen Y. In utero and early life arsenic exposure in relation to long-term health and disease. Toxicol Appl Pharmacol. 2013;272(2):384–90. doi:10.1016/j.taap.2013.06.030.

Tolins M, Ruchirawat M, Landrigan P. The developmental neurotoxicity of arsenic: cognitive and behavioral consequences of early life exposure. Ann Glob Health. 2014;80(4):303–14. doi:10.1016/j.aogh.2014.09.005.

Agency for Toxic Substances and Disease Registry (ATSDR). Public health statement. Arsenic. Division of Toxicology and Environmental Medicine. CAS#: 7440-38-2. (24.10.2024 tarihinde https://www.atsdr.cdc.gov/toxprofiles/tp2-c1-b.pdf. adresinden ulaşılmıştır).

Gielen M, Tiekink ER, editors. Metallotherapeutic drugs and metal-based diagnostic agents. The Use of Metals in Medicine. In: Ho PC. Metallotherapeutic Arsenic Compounds. Wiley & Sons Ltd.; 2005. p. 297–931. doi:10.1002/0470864052.ch16.

Wang S, Zhou M, Ouyang J, et al. Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells. PLoS One. 2015;10(6). doi:10.1371/journal.pone.0130343.

Ghaffari SH, Yousefi M, Dizaji MZ, et al. Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism. Asian Pac J Cancer Prev. 2016;17(3):1553–64. doi:10.7314/apjcp.2016.17.3.1553.

Sun XP, Zhang X, He C, et al. ABT-737 synergizes with arsenic trioxide to induce apoptosis of gastric carcinoma cells in vitro and in vivo. J Int Med Res. 2012;40(4):1251–64. doi:10.1177/147323001204000404.

Walker AM, Stevens JJ, Ndebele K, et al. Evaluation of arsenic trioxide potential for lung cancer treatment: assessment of apoptotic mechanisms and oxidative damage. J Cancer Sci Ther. 2016;8(1):1–9. doi:10.4172/1948-5956.1000379.

Hu HT, Yao QJ, Meng YL, et al. Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: long-term outcome analysis. J Gastroenterol Hepatol. 2017;32(2):295–300. doi:10.1111/jgh.13529.

Zhong L, Xu F, Chen F. Arsenic trioxide induces the apoptosis and decreases NF-κB expression in lymphoma cell lines. Oncol Lett. 2018;16(5):6267–74. doi:10.3892/ol.2018.9424.

World Health Organization (WHO). Hydrogen sulfide in drinking water. Background document for preparation of WHO Guidelines for drinking water quality. Geneva: World Health Organization; 2003. (15.10.2024 tarihinde https://cdn.who.int/media/docs/default-source/wash-documents/wash-chemicals/hydrogensulfide-bd.pdf?sfvrsn=2f03ad98_4. adresinden ulaşılmıştır).

Mahurpawar M. Effects of heavy metals on human health. Int J Res-GRANTHAALAYAH. 2015;3(9SE):1–7. doi:10.29121/granthaalayah.v3.i9SE.2015.3282.

Piver WT. Organotin compounds: industrial applications and biological investigation. Environ Health Perspect. 1973;4:61–9. doi:10.1289/ehp.730461.

Agency for Toxic Substances and Disease Registry (ATSDR). Public health statement. Tin and tin compounds. (15.10.2024 tarihinde https://www.atsdr.cdc.gov/. adresinden ulaşılmıştır).

Terao T. Is lithium potentially a trace element? World J Psychiatry. 2015;5(1):1–3. doi:10.5498/wjp.v5.i1.1.

Schou M. Possible mechanisms of action of lithium salts: approaches and perspectives. Biochem Soc Trans. 1973;1(1):81–7. doi:10.1042/bst0010081.

Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016;4(1):27. doi:10.1186/s40345-016-0068-y.

Kleiner J, Altshuler L, Hendrick V, et al. Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry. 1999;60(4):249–55.

Schwarz K. Essentiality versus toxicity of metals. In: Brown SS, editor. Clinical Chemistry and Chemical Toxicology of Metals. New York: Elsevier/North Holland; 1977. p. 3–22.

Baer L. Pharmacology—lithium absorption, distribution, renal handling, and effect on body electrolytes. In: Gershon S, Shopsin B, editors. Lithium. Boston: Springer; 1973. p. 33–49. doi:10.1007/978-1-4684-2022-7_4.

Jelani QU, Katz SD. Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease. Cardiol Rev. 2010;18(5):240–50. doi:10.1097/CRD.0b013e3181e71150.

Tsygan VN, Kamilova TA, Skalny AV, et al. Pathophysiology of Cells. Saint Petersburg: Medkniga ELBI-SPb; 2014. 128 p.

Kovac S, Smith K, Anderson GJ, et al. Interrelationships between circulating gastrin and iron status in mice and humans. Am J Physiol Gastrointest Liver Physiol. 2008;295(4)–61. doi:10.1152/ajpgi.90359.2008.

Díaz-Castro J, Pulido M, Alférez MJ, et al. Goat milk consumption modulates liver divalent metal transporter 1 (DMT1) expression and serum hepcidin during Fe repletion in Fe-deficiency anemia. J Dairy Sci. 2014;97(1):147–54. doi:10.3168/jds.2013-7250.

Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13(5):342–55. doi:10.1038/nrc3495.

Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol. 2009;122(2-3):78–86. doi:10.1159/000243791.

Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and the role of transferrin. Biochim Biophys Acta. 2012;1820(3):188–202. doi:10.1016/j.bbagen.2011.10.013.

Nemeth E, Ganz T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int J Mol Sci. 2021;22(12):6493. doi:10.3390/ijms22126493.

Meynard D, Babitt JL, Lin HY. The liver: conductor of systemic iron balance. Blood. 2014;123(2):168–76. doi:10.1182/blood-2013-06-427757.

Cellier MF. Nramp: from sequence to structure and mechanism of divalent metal import. Curr Top Membr. 2012;69:249–93. doi:10.1016/B978-0-12-394390-3.00010-0.

Mitchell CJ, Shawki A, Ganz T, et al. Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc. Am J Physiol Cell Physiol. 2014;306(5)–9. doi:10.1152/ajpcell.00348.2013.

Brabin L, Brabin BJ, Gies S. Influence of iron status on risk of maternal or neonatal infection and on neonatal mortality with an emphasis on developing countries. Nutr Rev. 2013;71(8):528–40. doi:10.1111/nure.12049.

Simonsen LO, Harbak H, Bennekou P. Cobalt metabolism and toxicology—a brief update. Sci Total Environ. 2012;432:210–5. doi:10.1016/j.scitotenv.2012.06.009.

Quadros EV, Nakayama Y, Sequeira JM. The binding properties of the human receptor for the cellular uptake of vitamin B12. Biochem Biophys Res Commun. 2005;327(4):1006–10. doi:10.1016/j.bbrc.2004.12.103.

Illing AC, Shawki A, Cunningham CL, et al. Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1. J Biol Chem. 2012;287(36):30485–96. doi:10.1074/jbc.M112.364208.

Simonsen LO, Harbak H, Bennekou P. Passive transport pathways for Ca(2+) and Co(2+) in human red blood cells. 57Co(2+) as a tracer for Ca(2+) influx. Blood Cells Mol Dis. 2011;47(4):214–25. doi:10.1016/j.bcmd.2011.09.002.

Zielazinski EL, Cutsail GE, Hoffman BM, et al. Characterization of a cobalt-specific P(1B)-ATPase. Biochemistry. 2012;51(40):7891–900. doi:10.1021/bi3006708.

Befani C, Mylonis I, Gkotinakou IM, et al. Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells. Int J Biochem Cell Biol. 2013;45(11):2359–68. doi:10.1016/j.biocel.2013.07.025.

Oberley MJ, Yang DT. Laboratory testing for cobalamin deficiency in megaloblastic anemia. Am J Hematol. 2013;88(6):522–6. doi:10.1002/ajh.23421.

Oh R, Brown DL. Vitamin B12 deficiency. Am Fam Physician. 2003;67(5):979–86.

Herrmann W, Obeid R. Cobalamin deficiency. Subcell Biochem. 2012;56:301–22. doi:10.1007/978-94-007-2199-9_16.

Takahashi-Iñiguez T, García-Hernandez E, Arreguín-Espinosa R, et al. Role of vitamin B12 on methylmalonyl-CoA mutase activity. J Zhejiang Univ Sci B. 2012;13(6):423–37. doi:10.1631/jzus.B1100329.

Kobayashi M, Shimizu S. Cobalt proteins. Eur J Biochem. 1999;261(1):1–9. doi:10.1046/j.1432-1327.1999.00186.x.